Xcout Intel
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Subscribe to see Aer Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aer Therapeutics, Inc. at a glance
Aer Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $23.9M across the 3 funding rounds on record. Its most recent funding round raised $3M in August 2026. Xcout tracks 15 named people at Aer Therapeutics, Inc., including Thomas P. Mathers (Executive Chairman and Interim CEO).
Aer Therapeutics, Inc. leadership
- Thomas P. MathersExecutive Chairman and Interim CEO
- Thomas MathersChairman of the Board of Directors
- John FahyFounder and Chief Clinical Consultant
- William Thelin, PhDSVP, Drug Development
- Irina Gitlin, PhDVice President, Research and Development
- Blair CapelSenior Director, Finance and Administration
9 more named people on record for Aer Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Aer Therapeutics, Inc. funding rounds
At least $23.9M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $15.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Aer Therapeutics, Inc. news
- FundingPrivate placement (Form D)
Aer Therapeutics, Inc. competitors
A few of Aer Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
AeroRx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic obstructive pulmonary disease (COPD).
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Aiolos Bio is a biotechnology research company headquartered in San Francisco, California, focused on developing novel treatments for respiratory and asthma conditions. The clinical-stage biopharmaceutical firm was acquired by GSK to strengthen its drug development pipeline.
RaeSedo Holding, Inc. is a biotechnology company developing a novel class of therapeutics for asthma. The company is creating surfactant protein-A (SP-A) derived peptide therapies designed to reduce inflammation, mucus, and airway constriction for asthma patients.
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company with principal executive offices located in Cambridge, Massachusetts. The company went public through a reverse merger and is involved in therapeutic acquisitions and development.
Get Aer Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Aer Therapeutics, Inc. in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access